Ambassador Eric Goosby serves as U.S. Global AIDS Coordinator and head of the Office of Global Health Diplomacy.
2012 was an extraordinary year.
As of September 30, 2012, PEPFAR directly supported lifesaving antiretroviral treatment (ART) for nearly 5.1 million people -- a nearly three-fold increase since 2008. PEPFAR also supported drugs to prevent mother-to-child transmission for nearly 750,000 HIV-positive women in 2012 alone, allowing approximately 230,000 infants to be born HIV-free, and HIV testing and counseling for more than 46.5 million people over the same time period.
These are not just statistics but they represent lives saved, and hope renewed for millions of families and communities. A decade ago, almost no one in Africa was receiving treatment. Today, over 8 million men, women, and children in developing countries are on ART, with the vast majority of them being in sub-Saharan Africa.
Every American should be profoundly proud of the United States' role in supporting this progress. Both President Obama and Secretary Clinton have repeatedly reaffirmed America's commitment to the global fight against AIDS through PEPFAR. In November 2011, the Secretary declared that the world is at the point where an AIDS-free generation is in sight. On World AIDS Day 2011, the President announced ambitious new PEPFAR prevention and treatment targets, which we are on track to reach by the end of 2013.
This past July, the 19th International AIDS Conference came to the U.S. for the first time since 1990. During the Conference, Secretary Clinton called on PEPFAR to develop a blueprint to inform the next Congress, the next Secretary of State, and all of our partners about all that we have learned, and how the U.S. will contribute to creating an AIDS-free generation moving forward. And in recognition of World AIDS Day 2012, the Secretary unveiled the PEPFAR Blueprint: Creating an AIDS-free Generation, which sends an unequivocal message that the U.S. commitment to the global AIDS response will remain strong, comprehensive, and driven by science.
